Consequently, both peripheral (blood) and central (brain) immune responses upon treatment with CCL11 were analyzed in the two mice groups, using flow cytometry on day 7 post-stroke (Figure 6 and Figure 7). The gene discussed is CCL11; the disease is stroke disorder.